arrow_back Trending Legislation
Share share

Fair Pharmacy Assessment and Transparency in Medicare Part D

New rules aim to ensure pharmacies are evaluated more fairly under Medicare Part D, potentially impacting service quality and drug access. They also introduce greater transparency in billing between pharmacies and insurers, which could help in better understanding drug costs.
Key points
Standardized rules for assessing pharmacy performance and quality in Medicare Part D will be implemented from 2025, aiming for fairer conditions for all pharmacies.
Increased transparency in pharmacy payments: insurers will be required to promptly provide pharmacies with detailed billing information for drugs, including fees and discounts.
The Office of the Inspector General will conduct a study on current pharmacy assessment and billing systems to identify issues and recommend improvements.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes.
Print number: HR 5393
Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
Process start date: 2023-09-12
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Fair Pharmacy Assessment and Transparency in Medicare Part D

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 5393.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-12.

What are the main provisions?

Key points include:

  • Standardized rules for assessing pharmacy performance and quality in Medicare Part D will be implemented from 2025, aiming for fairer conditions for all pharmacies.
  • Increased transparency in pharmacy payments: insurers will be required to promptly provide pharmacies with detailed billing information for drugs, including fees and discounts.
  • The Office of the Inspector General will conduct a study on current pharmacy assessment and billing systems to identify issues and recommend improvements.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Griffith, H. Morgan [R-VA-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 5393

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Benefits